Literature DB >> 6614164

Characterization of alpha-keto acid transport across blood-brain barrier in rats.

A R Conn, D I Fell, R D Steele.   

Abstract

The transport of keto acids, monocarboxylic acids, and ketone bodies was studied in barbiturate-anesthetized, adult male Sprague-Dawley rats. [1-14C]propionate and D-3-[3-14C]hydroxybutyrate were found to cross the blood-brain barrier with brain uptake indexes of 43.53 and 7.10%, respectively. Transport of both of these substrates was saturable, with the values of transport Km being 2.03 and 6.54 mM, respectively. A Ki of 0.68 mM was derived from competition data measuring the uptake of [1-14C]alpha-ketoisocaproate in the presence of unlabeled alpha-ketobutyrate. This finding and results from classical inhibition studies support competition for transport of keto acids for a common carrier. The brain uptake of [1-14C]propionate was significantly reduced by keto acids and ketone bodies and the transport of D-3-[3-14C]hydroxybutyrate was significantly inhibited by unlabeled monocarboxylic acids, keto acids, and acetoacetate. Evidence for competitive transport of alpha-keto acids, monocarboxylic acids, and ketone bodies is presented in the form of classical double-reciprocal inhibition plots and of labeled monocarboxylic acids and ketone bodies by an increasing concentration of unlabeled alpha-ketoisocaproate, the latter method yielding Ki values of 0.29 and 0.63 mM, respectively. The brain uptake of labeled propionate was inhibited by unlabeled D-3-hydroxybutyrate. A Ki of 6.43 mM, derived from this data, approximated the Km of transport of D-3-hydroxybutyrate, suggesting that ketone bodies and monocarboxylic acids compete for transport via the same carrier that is operative for keto acids.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6614164     DOI: 10.1152/ajpendo.1983.245.3.E253

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  27 in total

Review 1.  The Gut Microbiome and Multiple Sclerosis.

Authors:  Javier Ochoa-Repáraz; Trevor O Kirby; Lloyd H Kasper
Journal:  Cold Spring Harb Perspect Med       Date:  2018-06-01       Impact factor: 6.915

Review 2.  Control of brain development, function, and behavior by the microbiome.

Authors:  Timothy R Sampson; Sarkis K Mazmanian
Journal:  Cell Host Microbe       Date:  2015-05-13       Impact factor: 21.023

3.  Cortical substrate oxidation during hyperketonemia in the fasted anesthetized rat in vivo.

Authors:  Lihong Jiang; Graeme F Mason; Douglas L Rothman; Robin A de Graaf; Kevin L Behar
Journal:  J Cereb Blood Flow Metab       Date:  2011-07-06       Impact factor: 6.200

Review 4.  Metabolic tinkering by the gut microbiome: Implications for brain development and function.

Authors:  Joel Selkrig; Peiyan Wong; Xiaodong Zhang; Sven Pettersson
Journal:  Gut Microbes       Date:  2014-03-31

Review 5.  Opioid Use, Gut Dysbiosis, Inflammation, and the Nervous System.

Authors:  Richa Jalodia; Yaa Fosuah Abu; Mark Ryan Oppenheimer; Bridget Herlihy; Jingjing Meng; Irina Chupikova; Junyi Tao; Nillu Ghosh; Rajib Kumar Dutta; Udhghatri Kolli; Yan Yan; Eridania Valdes; Madhulika Sharma; Umakant Sharma; Shamsudheen Moidunny; Sabita Roy
Journal:  J Neuroimmune Pharmacol       Date:  2022-01-07       Impact factor: 4.147

6.  Pyruvate protects neurons against hydrogen peroxide-induced toxicity.

Authors:  S Desagher; J Glowinski; J Prémont
Journal:  J Neurosci       Date:  1997-12-01       Impact factor: 6.167

7.  Lactate utilization by the neonatal rat brain in vitro. Competition with glucose and 3-hydroxybutyrate.

Authors:  E Fernández; J M Medina
Journal:  Biochem J       Date:  1986-03-01       Impact factor: 3.857

8.  Effects of isoflurane anesthesia on hyperpolarized (13)C metabolic measurements in rat brain.

Authors:  Sonal Josan; Ralph Hurd; Kelvin Billingsley; Lasitha Senadheera; Jae Mo Park; Yi-Fen Yen; Adolf Pfefferbaum; Daniel Spielman; Dirk Mayer
Journal:  Magn Reson Med       Date:  2012-10-19       Impact factor: 4.668

Review 9.  The influence of gut-derived CD39 regulatory T cells in CNS demyelinating disease.

Authors:  Javier Ochoa-Repáraz; Lloyd H Kasper
Journal:  Transl Res       Date:  2016-07-28       Impact factor: 7.012

10.  The enteric bacterial metabolite propionic acid alters brain and plasma phospholipid molecular species: further development of a rodent model of autism spectrum disorders.

Authors:  Raymond H Thomas; Melissa M Meeking; Jennifer R Mepham; Lisa Tichenoff; Fred Possmayer; Suya Liu; Derrick F MacFabe
Journal:  J Neuroinflammation       Date:  2012-07-02       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.